Dow Pharmaceutical Asks Court To Block Generic Acne Gel

Law360, New York (October 28, 2013, 1:30 PM EDT) -- Dow Pharmaceutical Sciences Inc. filed a patent infringement suit in New Jersey federal court Thursday against Watson Laboratories Inc., Actavis Inc. and two related companies in an attempt to block their production of a generic form of Dow's anti-acne gel Acanya.

Dow and Bridgewater, N.J.-based Valeant Pharmaceuticals North America LLC say the rival drugmakers' abbreviated new drug application to the U.S. Food and Drug Administration to produce their own version of the topical treatment for acne vulgaris, the most common form of the skin condition that...
To view the full article, register now.